Clinical Trial: Phase IIT Trial of SNA009

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597759) titled 'Phase IIT Trial of SNA009' on April 21.

Brief Summary: This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.

Study Start Date: Oct. 30, 2025

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer GPA33

Intervention: DRUG: 68Ga-NODAGA-SNA009

68Ga-NODAGA-SNA009 is a radiopharmaceutical agents that targets GPA33

Recruitment Status: COMPLETED

Sponsor: SmartNuclide Biopharma

Published by HT Digital Content Services with permission from Health Daily Digest....